Dr. Johnstone et al. Reply to Dr. Elmrayed

Jeanette M Johnstone; L Eugene Arnold; Amelia Villagomez; Lisa M Robinette; Barbara L Gracious; Hayleigh K Ast; Alisha M Bruton; Irene E Hatsu

doi:10.1016/j.jaac.2023.07.994

Dr. Johnstone et al. Reply to Dr. Elmrayed

J Am Acad Child Adolesc Psychiatry. 2023 Nov;62(11):1171-1175. doi: 10.1016/j.jaac.2023.07.994. Epub 2023 Aug 3.

Authors

Jeanette M Johnstone¹, L Eugene Arnold², Amelia Villagomez³, Lisa M Robinette², Barbara L Gracious⁴, Hayleigh K Ast⁵, Alisha M Bruton⁵, Irene E Hatsu²

Affiliations

¹ Oregon Health & Science University, Portland, Oregon; National University of Natural Medicine, Helfgott Research Institute, Portland, Oregon. Electronic address: jojeanet@ohsu.edu.
² The Ohio State University, Columbus, Ohio.
³ University of Arizona College of Medicine, Tucson, Arizona.
⁴ HCA Florida Orange Park Hospital, Orange Park, Florida; Edward Via College of Osteopathic Medicine, Spartanburg, South Carolina.
⁵ Oregon Health & Science University, Portland, Oregon.

PMID: 37543077
DOI: 10.1016/j.jaac.2023.07.994

Abstract

We thank Dr. Elmrayed and colleagues¹ for highlighting clinical cautions in using broad-spectrum micronutrients to treat attention-deficit/hyperactivity disorder (ADHD) in children, in particular manganese (Mn) levels. We appreciate the opportunity to provide additional information and rationale for the vitamin and mineral doses contained in the studied formula.

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Attention Deficit Disorder with Hyperactivity* / drug therapy
Child
Humans
Micronutrients / therapeutic use

Substances

Micronutrients

Abstract

Publication types

MeSH terms

Substances

Grants and funding